Ankylosing spondylitis

Citations 11-20 of 196 total displayed.

Basic and translational research
Ankylosing spondylitis monocytes show upregulation of proteins involved in inflammation and the ubiquitin proteasome pathway

C Wright, M Edelmann, K diGleria, S Kollnberger, H Kramer, S McGowan, K McHugh, S Taylor, B Kessler, and P Bowness
Ann Rheum Dis 2009 68: 1626 -1632; published online before print as 10.1136/ard.2008.097204 [Abstract] [Full text] [PDF] [Request Permissions] [ Web only data ]  

Recommendation
ASAS/EULAR recommendations for the management of ankylosing spondylitis: the patient version

U Kiltz, D van der Heijde, H Mielants, E Feldtkeller, J Braun, and on behalf of the PARE/EULAR patient initiative group
Ann Rheum Dis 2009 68: 1381 -1386; published online before print as 10.1136/ard.2008.096073 [Abstract] [Full text] [PDF] [Request Permissions] [ Web Only Data ]  

Clinical and epidemiological research
Comparison of clinical and radiographic severity of juvenile-onset versus adult-onset ankylosing spondylitis

F D O’Shea, E Boyle, R Riarh, S M Tse, R M Laxer, and R D Inman
Ann Rheum Dis 2009 68: 1407 -1412; published online before print as 10.1136/ard.2008.092304 [Abstract] [Full text] [PDF] [Request Permissions]  

Clinical and epidemiological research
MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib

S J Jarrett, F Sivera, L S Cawkwell, H Marzo-Ortega, D McGonagle, E Hensor, L Coates, P J O’Connor, A Fraser, P G Conaghan, and P Emery
Ann Rheum Dis 2009 68: 1466 -1469; published online before print as 10.1136/ard.2008.092213 [Abstract] [Full text] [PDF] [Request Permissions]  

Editorials
How to dose infliximab in rheumatoid arthritis: new data on a serious issue

Ronald F van Vollenhoven
Ann Rheum Dis 2009; 68: 1237-1239. [Extract] [Full text] [PDF] [Request Permissions]  

Clinical and epidemiological research
Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study

P J Mease, K Hobbs, A Chalmers, H El-Gabalawy, A Bookman, E Keystone, D E Furst, P Anklesaria, and A E Heald
Ann Rheum Dis 2009 68: 1247 -1254; published online before print as 10.1136/ard.2008.089375 [Abstract] [Full text] [PDF] [Request Permissions]  

Basic and translational research
Expression of cathepsin K and matrix metalloproteinase 1 indicate persistent osteodestructive activity in long-standing ankylosing spondylitis

M Neidhart, X Baraliakos, C Seemayer, C Zelder, R E Gay, B A Michel, H Boehm, S Gay, and J Braun
Ann Rheum Dis 2009 68: 1334 -1339; published online before print as 10.1136/ard.2008.092494 [Abstract] [Full text] [PDF] [Request Permissions]  

Basic and translational research
Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis

J E Hollis-Moffatt, M E Merriman, R A Rodger, K A Rowley, P T Chapman, N Dalbeth, P J Gow, A A Harrison, J Highton, P B B Jones, J L O’Donnell, L K Stamp, and T R Merriman
Ann Rheum Dis 2009 68: 1340 -1344; published online before print as 10.1136/ard.2008.090142 [Abstract] [Full text] [PDF] [Request Permissions]  

Basic and translational research
Regulatory IL4+CD8+ T cells in patients with ankylosing spondylitis and healthy controls

L Zhang, L B Jarvis, H-J Baek, and J S Hill Gaston
Ann Rheum Dis 2009 68: 1345 -1351; published online before print as 10.1136/ard.2008.088120 [Abstract] [Full text] [PDF] [Request Permissions] [ Web Only Data ]  

Editorials
Diagnosing axial spondyloarthropathy. The new Assessment in SpondyloArthritis international Society criteria: MRI entering centre stage

A N Bennett, H Marzo-Ortega, P Emery, D McGonagle on behalf of the Leeds Spondyloarthropathy Group
Ann Rheum Dis 2009; 68: 765-767. [Extract] [Full text] [PDF] [Request Permissions]